AMAthina Marina Metaxa

Athina Marina Metaxa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Athina Marina Metaxa has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness of Telehealth Care Interventions for Women’s Mental Health During and After the COVID-19 Pandemic: Systematic Review and Meta-Analysis

    by Serena Kao, Athina Marina Metaxa, Ranin Soliman, Ioannis Mitrogiannis, Francesco Rubino, Anastasija Arechvo, Valeria Mondelli

    Background: The COVID-19 pandemic has increased telemental health interventions. However, evidence of effectiveness in improving women’s mental health outcomes, acceptability, and user satisfaction remains fragmented. Objective: This study examined the effectiveness of telehealth interventions in alleviating depression, anxiety, and stress in women during and after the pandemic and descriptively summarized the acceptability of and satisfaction with these interventions. Methods: This systematic review and meta-analysis compared telemental health interventions with control conditions (waitlists or standard care) for women experiencing anxiety, depression, or stress. Databases (PubMed/MEDLINE, Embase, Web of Science, PsycINFO, and Cochrane Central Register of Controlled Trials) were searched through March 19, 2026. Eligible studies evaluated interventions in women aged 18 to 64 years (≥80% female participants and female-specific outcomes) and included randomized controlled trials (RCTs), nonrandomized trials, and observational studies with ≥5 participants using outcome measures. Random-effects meta-analyses were conducted for depression, anxiety, and stress using RCT data. Risk of bias was assessed using Cochrane tools and certainty of evidence using Grading of Recommendations, Assessment, Development and Evaluation. Results: Fifty-seven studies (N=13,457) from 24 countries, reported the effectiveness, acceptability, and satisfaction with telehealth interventions. Meta-analysis of 23 studies (n=3269) demonstrated significant benefits of telehealth interventions for depression, anxiety, and stress. Depression showed the greatest improvements, with a moderate reduction in symptoms (Hedges g =−0.56, 95% CI −0.86 to −0.26; P <.001), followed by anxiety (small to moderate reduction; Hedges g =−0.45, 95% CI −0.62 to −0.28; P <.001). Stress showed a smaller effect (Hedges g =−0.25, 95% CI −0.47 to −0.04; P =.02), indicating modest benefits. Heterogeneity was high, with 95% prediction intervals of −1.97 to 0.84, −1.11 to 0.21, and −0.98 to 0.40 for depression, anxiety, and stress, respectively. Subgroup analyses favored telehealth over waitlist and standard care for depression (waitlist: Hedges g =−0.60, 95% CI −0.86 to −0.33; standard care: Hedges g =−0.57, 95% CI −1.11 to −0.02; both P <.001) and anxiety (waitlist: Hedges g =−0.47, 95% CI −0.68 to −0.25; standard care: Hedges g =−0.52, 95% CI −0.80 to −0.25; both P <.001). Insufficient studies were available to evaluate stress in subgroup analyses. Treatment effects remained significant in female-only and predominantly female samples. Evidence certainty was downgraded due to heterogeneity, risk of bias, and methodological limitations. Conclusions: This is the first systematic review and meta-analysis focused on telemental health interventions for women. Telehealth was associated with moderate, small to moderate, and modest reductions in depression, anxiety, and stress, respectively, with benefits across female-only and predominantly female samples. Moderate to high heterogeneity in average effects (CIs), wide distributions of effects across settings (prediction intervals), and risk of bias resulted in moderate certainty of evidence. Overall, telehealth is a scalable approach for improving access to mental health care for women, although high-quality research is needed to strengthen the evidence base.

  • Open Access

    Identification and Predictive Analysis of Revenue Determinants in the Pharma Industry: A Longitudinal Analysis of Financial, Regulatory and Pipeline Data

    by Rusne Sipelyte, Athina Marina Metaxa

    Purpose: Maintaining positive revenue performance and R&D productivity is crucial for the pharma industry, therefore identifying and predicting future revenue determinants is of upmost importance. The aim of the study was to identify factors that determine annual revenue and to use these factors to develop a model that predicts future revenues. Methods: IDEA Pharma’s longitudinal Pharmaceutical Innovation and Invention Index data were used to conduct the analyses, looking at the financial, regulatory and pipeline data (2019–2023) of the top 24 pharmaceutical companies. Broader industry trends over the last 5 years were analysed using descriptive statistics. To validate the factors gleaned from the descriptive statistics, a predictive model was constructed. This was done through predictive statistical analysis (stepwise regression), producing a model that can predict future revenue. Results: Three factors were determined to be significant determinants of higher future revenues: higher R&D spend, lower R&D spend as a proportion of current revenue, and higher number of Phase III clinical trials. Conclusions: The resulting model combined financial, commercial, and strategic metrics from the world’s largest pharmaceutical companies to produce a statistically robust method of predicting revenues, that is critical for every pharma company’s growth and strategic planning.

  • Open Access

    Improving Mental Health and Well-Being Through the Paradym App: Quantitative Study of Real-World Data

    by Athina Marina Metaxa, Shaun Liverpool, Mia Eisenstadt, John Pollard, Courtney Carlsson

    Background: With growing evidence suggesting that levels of emotional well-being have been decreasing globally over the past few years, demand for easily accessible, convenient, and affordable well-being and mental health support has increased. Although mental health apps designed to tackle this demand by targeting diagnosed conditions have been shown to be beneficial, less research has focused on apps aiming to improve emotional well-being. There is also a dearth of research on well-being apps structured around users’ lived experiences and emotional patterns and a lack of integration of real-world evidence of app usage. Thus, the potential benefits of these apps need to be evaluated using robust real-world data. Objective: This study aimed to explore usage patterns and preliminary outcomes related to mental health and well-being among users of an app (Paradym; Paradym Ltd) designed to promote emotional well-being and positive mental health. Methods: This is a pre-post, single-arm evaluation of real-world data provided by users of the Paradym app. Data were provided as part of optional built-in self-assessments that users completed to test their levels of depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder Questionnaire-7), life satisfaction (Satisfaction With Life Scale), and overall well-being (World Health Organization-5 Well-Being Index) when they first started using the app and at regular intervals following initial usage. Usage patterns, including the number of assessments completed and the length of time between assessments, were recorded. Data were analyzed using within-subjects t tests, and Cohen d estimates were used to measure effect sizes. Results: A total of 3237 app users completed at least 1 self-assessment, and 787 users completed a follow-up assessment. The sample was diverse, with 2000 users (61.8%) being located outside of the United States. At baseline, many users reported experiencing strong feelings of burnout (677/1627, 41.6%), strong insecurities (73/211, 34.6%), and low levels of thriving (140/260, 53.8%). Users also experienced symptoms of depression (mean 9.85, SD 5.55) and anxiety (mean 14.27, SD 6.77) and reported low levels of life satisfaction (mean 12.14, SD 7.42) and general well-being (mean 9.88, SD 5.51). On average, users had been using the app for 74 days when they completed a follow-up assessment. Following app usage, small but significant improvements were reported across all outcomes of interest, with anxiety and depression scores improving by 1.20 and 1.26 points on average, respectively, and life satisfaction and well-being scores improving by 0.71 and 0.97 points, respectively. Conclusions: This real-world data analysis and evaluation provided positive preliminary evidence for the Paradym app’s effectiveness in improving mental health and well-being, supporting its use as a scalable intervention for emotional well-being, with potential applications across diverse populations and settings, and encourages the use of built-in assessments in mental health app research.

  • Open Access

    Improving Mental Health and Well-Being Through the Paradym App: Quantitative Study of Real-World Data (Preprint)

    by Athina Marina Metaxa, Shaun Liverpool, Mia Eisenstadt, John Pollard, Courtney Carlsson

    BACKGROUND With growing evidence suggesting that levels of emotional well-being have been decreasing globally over the past few years, demand for easily accessible, convenient, and affordable well-being and mental health support has increased. Although mental health apps designed to tackle this demand by targeting diagnosed conditions have been shown to be beneficial, less research has focused on apps aiming to improve emotional well-being. There is also a dearth of research on well-being apps structured around users’ lived experiences and emotional patterns and a lack of integration of real-world evidence of app usage. Thus, the potential benefits of these apps need to be evaluated using robust real-world data. OBJECTIVE This study aimed to explore usage patterns and preliminary outcomes related to mental health and well-being among users of an app (Paradym; Paradym Ltd) designed to promote emotional well-being and positive mental health. METHODS This is a pre-post, single-arm evaluation of real-world data provided by users of the Paradym app. Data were provided as part of optional built-in self-assessments that users completed to test their levels of depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder Questionnaire-7), life satisfaction (Satisfaction With Life Scale), and overall well-being (World Health Organization-5 Well-Being Index) when they first started using the app and at regular intervals following initial usage. Usage patterns, including the number of assessments completed and the length of time between assessments, were recorded. Data were analyzed using within-subjects t tests, and Cohen d estimates were used to measure effect sizes. RESULTS A total of 3237 app users completed at least 1 self-assessment, and 787 users completed a follow-up assessment. The sample was diverse, with 2000 users (61.8%) being located outside of the United States. At baseline, many users reported experiencing strong feelings of burnout (677/1627, 41.6%), strong insecurities (73/211, 34.6%), and low levels of thriving (140/260, 53.8%). Users also experienced symptoms of depression (mean 9.85, SD 5.55) and anxiety (mean 14.27, SD 6.77) and reported low levels of life satisfaction (mean 12.14, SD 7.42) and general well-being (mean 9.88, SD 5.51). On average, users had been using the app for 74 days when they completed a follow-up assessment. Following app usage, small but significant improvements were reported across all outcomes of interest, with anxiety and depression scores improving by 1.20 and 1.26 points on average, respectively, and life satisfaction and well-being scores improving by 0.71 and 0.97 points, respectively. CONCLUSIONS This real-world data analysis and evaluation provided positive preliminary evidence for the Paradym app’s effectiveness in improving mental health and well-being, supporting its use as a scalable intervention for emotional well-being, with potential applications across diverse populations and settings, and encourages the use of built-in assessments in mental health app research.

  • Top Cited Papers
    Open Access

    Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis

    by Athina-Marina Metaxa, Mike Clarke

    Objective To determine the efficacy of psilocybin as an antidepressant compared with placebo or non-psychoactive drugs. Design Systematic review and meta-analysis. Data sources Five electronic databases of published literature (Cochrane Central Register of Controlled Trials, Medline, Embase, Science Citation Index and Conference Proceedings Citation Index, and PsycInfo) and four databases of unpublished and international literature (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, ProQuest Dissertations and Theses Global, and PsycEXTRA), and handsearching of reference lists, conference proceedings, and abstracts. Data synthesis and study quality Information on potential treatment effect moderators was extracted, including depression type (primary or secondary), previous use of psychedelics, psilocybin dosage, type of outcome measure (clinician rated or self-reported), and personal characteristics (eg, age, sex). Data were synthesised using a random effects meta-analysis model, and observed heterogeneity and the effect of covariates were investigated with subgroup analyses and metaregression. Hedges’ g was used as a measure of treatment effect size, to account for small sample effects and substantial differences between the included studies’ sample sizes. Study quality was appraised using Cochrane’s Risk of Bias 2 tool, and the quality of the aggregated evidence was evaluated using GRADE guidelines. Eligibility criteria Randomised trials in which psilocybin was administered as a standalone treatment for adults with clinically significant symptoms of depression and change in symptoms was measured using a validated clinician rated or self-report scale. Studies with directive psychotherapy were included if the psychotherapeutic component was present in both experimental and control conditions. Participants with depression regardless of comorbidities (eg, cancer) were eligible. Results Meta-analysis on 436 participants (228 female participants), average age 36-60 years, from seven of the nine included studies showed a significant benefit of psilocybin (Hedges’ g=1.64, 95% confidence interval (CI) 0.55 to 2.73, PConclusion Treatment effects of psilocybin were significantly larger among patients with secondary depression, when self-report scales were used to measure symptoms of depression, and when participants had previously used psychedelics. Further research is thus required to delineate the influence of expectancy effects, moderating factors, and treatment delivery on the efficacy of psilocybin as an antidepressant. Systematic review registration PROSPERO CRD42023388065.


  • Open Access

    Acceptability, Engagement, and Exploratory Outcomes of an Emotional Well-being App: Mixed Methods Preliminary Evaluation and Descriptive Analysis

    by Amelia Eisenstadt, Shaun Liverpool, Athina-Marina Metaxa, Roberta Maria Ciuvat, Courtney Carlsson

    Background: There is growing evidence suggesting that the emotional well-being of the public has been negatively affected in the past year. Consequently, demand for well-being support has increased. Although there is substantial empirical support for mental health apps that target diagnosed conditions, there is less research on emotional well-being apps. Among existing well-being apps, few studies have been conducted on apps that are based on lived experience and those that seek to enhance users’ understanding of their emotional patterns. Thus, the acceptability of these novel apps requires further evaluation before upscaling. Objective: This evaluation aims to describe the acceptability, engagement, and preliminary outcomes of using an app (Paradym) designed to promote emotional well-being and positive mental health. Methods: This is a pre-post, mixed-methods, single-arm evaluation that is aggregated with digital analytics data. We anonymously collected real-world data on the demographics and well-being of the participants as well as the usability and acceptance of the app using validated questionnaires and open-ended questions. Participants tested the app for a minimum of 2 weeks before completing the follow-up measures. Google Analytics was used to record the level of app engagement. Chi-square and 2-tailed t tests were conducted to analyze quantitative data, and a thematic analysis approach was adopted for qualitative data. Results: A total of 115 participants completed baseline questionnaires, of which 79.1% (91/115) users downloaded the app. The sample was diverse in terms of ethnicity, including 43.4% (50/115) people who self-identified as belonging to minority ethnic groups. Most of the participants were female (78/115, 67.8%) and between the ages of 18 and 25 years (39/115, 33.9%). A total of 34 app users who completed questionnaires at baseline and follow-up provided valuable feedback to inform the future directions of Paradym. Favorable themes emerged describing the app’s content, functionality, and underlying principles. Although usability feedback varied across items, a considerable number of participants (22/34, 64%) found that the app was easy to use. Google Analytics revealed that at least 79% (27/34) of people used the app daily. On the basis of preliminary observations, app users experience increased mental well-being. Post hoc analyses indicated that the reduction in depression scores (t33=−2.16) and the increase in the well-being measures (t33=2.87) were statistically significant. No adverse events were reported during the follow-up period. Conclusions: The findings of this evaluation are encouraging and document positive preliminary evidence for the Paradym app.


  • Open Access

    Acceptability, Engagement, and Exploratory Outcomes of an Emotional Well-being App: Mixed Methods Preliminary Evaluation and Descriptive Analysis (Preprint)

    by Amelia Eisenstadt, Shaun Liverpool, Athina-Marina Metaxa, Roberta Maria Ciuvat, Courtney Carlsson

    BACKGROUND There is growing evidence suggesting that the emotional well-being of the public has been negatively affected in the past year. Consequently, demand for well-being support has increased. Although there is substantial empirical support for mental health apps that target diagnosed conditions, there is less research on emotional well-being apps. Among existing well-being apps, few studies have been conducted on apps that are based on lived experience and those that seek to enhance users’ understanding of their emotional patterns. Thus, the acceptability of these novel apps requires further evaluation before upscaling. OBJECTIVE This evaluation aims to describe the acceptability, engagement, and preliminary outcomes of using an app (Paradym) designed to promote emotional well-being and positive mental health. METHODS This is a pre-post, mixed-methods, single-arm evaluation that is aggregated with digital analytics data. We anonymously collected real-world data on the demographics and well-being of the participants as well as the usability and acceptance of the app using validated questionnaires and open-ended questions. Participants tested the app for a minimum of 2 weeks before completing the follow-up measures. Google Analytics was used to record the level of app engagement. Chi-square and 2-tailed t tests were conducted to analyze quantitative data, and a thematic analysis approach was adopted for qualitative data. RESULTS A total of 115 participants completed baseline questionnaires, of which 79.1% (91/115) users downloaded the app. The sample was diverse in terms of ethnicity, including 43.4% (50/115) people who self-identified as belonging to minority ethnic groups. Most of the participants were female (78/115, 67.8%) and between the ages of 18 and 25 years (39/115, 33.9%). A total of 34 app users who completed questionnaires at baseline and follow-up provided valuable feedback to inform the future directions of Paradym. Favorable themes emerged describing the app’s content, functionality, and underlying principles. Although usability feedback varied across items, a considerable number of participants (22/34, 64%) found that the app was easy to use. Google Analytics revealed that at least 79% (27/34) of people used the app daily. On the basis of preliminary observations, app users experience increased mental well-being. Post hoc analyses indicated that the reduction in depression scores (t33=−2.16) and the increase in the well-being measures (t33=2.87) were statistically significant. No adverse events were reported during the follow-up period. CONCLUSIONS The findings of this evaluation are encouraging and document positive preliminary evidence for the Paradym app.